Chris Barnes

Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy

Physical interventions to interrupt or reduce the spread of respiratory viruses

EFFICACY OF REVEFENACIN BY NEBULIZATION AND TIOTROPIUM BY HANDIHALER IN SUBJECTS WITH COPD AND SUBOPTIMAL PEAK INSPIRATORY FLOW RATES (PIFR)

737 A PHASE-I, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SINGLE ESCALATING ORAL DOSES OF GS-9620 IN HEALTHY SUBJECTS